Quantcast

Latest Cancer immunotherapy Stories

2015-04-08 08:29:55

NEW YORK and ANN ARBOR, Mich., April 8, 2015 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company developing breakthrough

2015-04-06 08:28:46

SAN DIEGO, April 6, 2015 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.

2015-04-02 23:02:19

New research report “Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons,

2015-03-30 20:24:35

SEATTLE, March 30, 2015 /PRNewswire/ -- TapImmune Inc.

2015-03-27 08:27:09

MARLBOROUGH, Mass., March 27, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive license

2015-03-24 04:26:45

BONN, Germany, March 24, 2015 /PRNewswire/ -- Brings Series A total to EUR14.25m to advance RNA-based immunotherapeutics for

2015-03-19 08:27:09

NEW YORK and ANN ARBOR, Mich., March 19, 2015 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company developing breakthrough medicines

2015-03-19 08:26:39

LOS ANGELES and MAASTRICHT, The Netherlands, March 19, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.

2015-03-17 08:31:15

SEATTLE, March 17, 2015 /PRNewswire/ -- Adaptive Biotechnologies Corporation, the pioneer in leveraging next generation sequencing to profile T-cell and B-cell receptors, today announced that members